Financial Data and Key Metrics Changes - The company reported a 5% decline in total adjusted EBITDA, primarily due to weaker performance in Mexico [6][9] - Adjusted net income for the quarter was PEN 58 million, with a 1% increase in FX-neutral consolidated revenue driven by Peru and Colombia [9][18] - Capacity utilization decreased by 3 percentage points to 64%, with a 1.5 percentage point increase in Peru offset by declines in Colombia and Mexico [9][10] Business Line Data and Key Metrics Changes - Peru's top line and EBITDA grew by 9% and 15% respectively, driven by an improving healthcare pricing mix and strong insurance MLR [7][18] - Colombia's revenue increased by 5%, supported by risk-sharing models, with adjusted EBITDA rising by 18% [19][18] - Mexico experienced a 12% decline in revenue, although surgery volumes and oncology services showed growth [11][12] Market Data and Key Metrics Changes - Peru accounted for over half of the company's revenues, with a solid growth trajectory [21] - Colombia's revenue share from Nueva EPS decreased from 20% to 13%, indicating successful diversification of payers [19][45] - Mexico's revenue decline was attributed to a slow recovery in volumes and non-operating impacts from system migrations [21][9] Company Strategy and Development Direction - The company aims to enhance its growth in Mexico through a partnership with Sojitz, focusing on co-investment opportunities [32][39] - Auna is committed to maintaining a leverage ratio below three times net debt to EBITDA while pursuing growth initiatives [28][32] - The Trecca project in Peru is expected to generate significant revenue, with a focus on expanding services to state beneficiaries [53][56] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism for a recovery in Mexico in 2026, despite current challenges [8][32] - The company remains focused on improving operational efficiency and expanding its market presence in Peru and Colombia [30][31] - Management highlighted the importance of attracting and retaining healthcare talent in Mexico to drive growth [13][15] Other Important Information - The company successfully refinanced $765 million in debt, improving its debt profile and financial flexibility [27][28] - Auna's cash position at the end of the quarter was PEN 226 million, reflecting a 4.2% decrease from the beginning of the year [26] Q&A Session Summary Question: Could you explain the rationale for expanding in Mexico and how it aligns with your deleveraging goals? - Management emphasized that the partnership with Sojitz will help accelerate growth in Mexico while maintaining leverage targets [39][40] Question: Do you think a change in Colombia's leadership could ease pressures on EPSs? - Management indicated that while political changes may not yield immediate results, there are signs of stabilization in the Colombian healthcare sector [40][41] Question: What key KPIs should be tracked to confirm a recovery in 2026? - Management suggested monitoring occupancy, payer mix, and surgical productivity as indicators of recovery [61] Question: What is the nature of the $500 million investment plan in Mexico? - Management confirmed that the investment plan is related to the MOU with Sojitz and aims to drive significant top-line growth [72] Question: How is Auna managing insurance risk at a group level? - Management explained that risk is managed through continuous repricing and cost containment strategies [75][78] Question: Have the preferred payer network and bundled packages for corporates been launched? - Management confirmed that the preferred payer network has been launched and is continuously evolving [79][80]

Financial Data and Key Metrics Changes - The company reported weaker financial results for Q3 2025, with a 5% decline in total adjusted EBITDA primarily due to performance in Mexico [6][9] - Adjusted net income was PEN 58 million for the quarter, with FX-neutral consolidated revenue increasing by 1% [9][24] - Capacity utilization decreased by 3 percentage points to 64%, with a 1.5 percentage point increase in Peru offset by declines in Colombia and Mexico [9][10] Business Line Data and Key Metrics Changes - Peru's top line and EBITDA grew by 9% and 15% respectively, driven by an improving healthcare pricing mix and strong insurance MLR [7][18] - Colombia's revenue increased by 5%, supported by risk-sharing models, while adjusted EBITDA grew by 18% [19][21] - Mexico experienced a 12% revenue decline, although surgery volumes and oncology services showed growth [9][11] Market Data and Key Metrics Changes - Peru accounted for over half of the company's revenues, with a solid growth trajectory [21] - Colombia's revenue share from Nueva EPS decreased from 20% to 13%, indicating successful diversification [19][45] - Mexico's revenue decline was attributed to a slow recovery in volumes and non-operating impacts from system migrations [21][24] Company Strategy and Development Direction - The company aims to capture long-term growth opportunities in Mexico, anticipating a full recovery in 2026 [8][32] - Auna is focusing on enhancing its oncology capabilities and expanding its service offerings in Mexico [16][14] - The partnership with Sojitz is expected to accelerate growth in Mexico while maintaining leverage targets [39][72] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenges in Mexico but expressed optimism about future growth and recovery [6][32] - The company remains committed to improving its leverage ratio and enhancing shareholder value [27][62] - Management highlighted the resilience of its integrated model and the potential for growth in Peru and Colombia despite external challenges [30][41] Other Important Information - Auna successfully completed a $765 million debt refinancing, improving its debt profile and financial flexibility [27][28] - The company is implementing a new comprehensive IT system to enhance operational efficiency and data management [17][12] Q&A Session Summary Question: Could you explain the rationale for expanding in Mexico and how it aligns with your goal to deleverage Auna? - Management emphasized that Auna is a growth story and sees significant opportunities in Mexico, with the partnership with Sojitz facilitating this growth while maintaining leverage targets [39][40] Question: Do you think a potential change in Colombia's leadership could ease pressures on EPSs? - Management indicated that while political changes may not have immediate effects, there are signs of stabilization in the Colombian healthcare sector [40][45] Question: What key KPIs should be tracked to confirm a tangible recovery in 2026? - Management suggested monitoring occupancy, payer mix, and surgical productivity as key indicators of recovery [61] Question: Could you provide more details around the partnership with Sojitz and the TRECA project? - Management confirmed that the TRECA project is a significant public-private partnership that will enhance Auna's service capabilities in Peru [52][53] Question: How do you plan to increase out-of-pocket sales mix in Mexico? - Management outlined initiatives to aggressively capture out-of-pocket patients through packaged services and improved pricing strategies [80][81]

Financial Data and Key Metrics Changes - The company reported weaker financial results for Q3 2025, with a 5% decline in total adjusted EBITDA primarily due to performance in Mexico [6][9] - Adjusted net income was PEN 58 million for the quarter, with FX-neutral consolidated revenue increasing by 1% [9][22] - Capacity utilization decreased by 3 percentage points to 64%, with a 1.5 percentage point increase in Peru offset by declines in Colombia and Mexico [9][10] Business Line Data and Key Metrics Changes - Peru's revenue grew by 9% and adjusted EBITDA increased by 15%, driven by improved healthcare pricing mix and strong insurance MLR [9][19] - Colombia's revenue grew by 5%, with adjusted EBITDA increasing by 18%, attributed to risk-sharing models and higher average tickets for surgery [20][21] - Mexico experienced a 12% revenue decline, although surgery volumes and oncology services increased [11][12] Market Data and Key Metrics Changes - Peru accounted for over half of the company's revenues, continuing to be a strong growth driver [21] - Colombia's share of revenues from major government payers decreased from 20% to 13%, indicating successful diversification efforts [20][21] - Mexico's revenue decline was influenced by a slower market and operational challenges, including the implementation of new IT systems [12][21] Company Strategy and Development Direction - The company is focused on capturing long-term growth opportunities in Mexico, anticipating a full recovery in 2026 [8][30] - Auna is rolling out new service offerings and enhancing collaboration with physicians to penetrate profitable market segments [14][15] - The partnership with Sojitz Corporation aims to accelerate growth in Mexico while maintaining a disciplined deleveraging path [31][35] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about Mexico's recovery, highlighting stable hospital operations and increased service volumes [6][8] - The company remains committed to improving its leverage ratio to below three times net debt to EBITDA in the medium term [26][27] - Management acknowledged the challenges in Colombia but emphasized the strength of Auna's positioning and growth potential [36][38] Other Important Information - Auna successfully refinanced $765 million in debt, improving its debt profile and extending maturities [26][27] - The company is implementing a comprehensive IT system to enhance operational efficiency and data management [18] Q&A Session Summary Question: Future strategy in Mexico and the rationale for expanding - Management clarified that the partnership with Sojitz is aimed at accelerating growth in Mexico while maintaining leverage targets [34][35] Question: Potential changes in Colombia's leadership and their impact - Management indicated that while political changes may not yield immediate improvements, there are signs of stabilization in the Colombian healthcare sector [36][38] Question: Key KPIs to track for recovery in 2026 - Management highlighted occupancy, payer mix, and surgical productivity as critical KPIs to monitor for tangible recovery [44] Question: Recent share price weakness and institutional investor activity - Management noted that the current share price does not reflect the company's fundamentals and is evaluating options to enhance shareholder value [45] Question: Return on investment timeline for Mexico performance - Management expects 2026 to be a growth year for Mexico, despite setbacks in 2025 [47] Question: Expansion plans in Peru and Mexico - Management confirmed plans to increase capacity in both countries, focusing on high-complexity services [48] Question: Details on the partnership with Sojitz and investment plans - Management confirmed that the $500 million investment plan is related to the MoU with Sojitz, aimed at significant top-line growth [49][50]

Q3 2025 This presentation has been prepared by Auna S.A. ("Auna" or the "Company") solely for use at this presentation. This presentation is confidential to the recipient. Accordingly, any attempt to copy, summarize or distribute this presentation or any portion hereof in any form to any other party without the Company's prior written consent is prohibited. This presentation contains forward-looking statements. Forward-looking statements convey our current expectations or forecasts of future events. These s ...

Core Insights - Auna reported solid financial and operational performance in Peru and Colombia, while facing challenges in Mexico, indicating resilience in its integrated healthcare platform [3][4][6] Financial Performance - Consolidated Revenue increased by 1% in constant currency (FXN) but decreased by 1% year-over-year (YoY) to S/1,117 million, with local currency revenues growing by 9% in Peru and 4% in Colombia, offset by a 12% decline in Mexico [8][10] - Adjusted EBITDA decreased by 5% FXN and 7% YoY to S/232 million, with a margin of 20.8%, down from 22.1% YoY; Peru and Colombia saw increases of 15% and 18% in local currency, respectively, while Mexico experienced a 29% decline [8][11] - Net Income was S/53 million in 3Q25, down from S/101 million in 3Q24, with Adjusted Net Income at S/58 million compared to S/75 million in the prior year [13] Operational Highlights - In Peru, Oncosalud and Healthcare Services showed strong performance due to growth in memberships and pricing adjustments, with an improved Oncology Medical Loss Ratio (MLR) of 49.3% [4][8] - Colombia achieved double-digit growth in Adjusted EBITDA and expanded risk-sharing Prospective Global Payment models, enhancing profitability and cash generation [5][8] - Mexico's operations saw a second consecutive quarterly increase in surgeries and growth in oncology and cardiology services, but overall revenues and profitability declined due to sluggish demand and operational challenges [6][10] Debt and Capital Structure - Auna's leverage ratio remained stable at 3.6x Net Debt-to-Adjusted EBITDA, with a focus on capital allocation and a robust cash position; the company completed a USD765 million debt refinancing to extend maturities and reduce interest costs [7][8] Strategic Initiatives - The company is focused on recovering growth, rolling out the AunaWay initiative in Mexico, and expanding access to high-quality healthcare across Spanish-speaking Latin America [9][10]

Core Insights - Auna S.A. has entered a Memorandum of Understanding with Sojitz Corporation to explore joint business opportunities in the healthcare sector across Latin America, initially focusing on Mexico [1][2][3] - Auna plans to invest approximately US$500 million over the next three to five years to expand its integrated healthcare platform in Mexico [2] - The collaboration aims to leverage Auna's healthcare expertise and Sojitz's investment capabilities to enhance healthcare infrastructure and services in Latin America [2][4] Company Overview - Auna is a leading healthcare services provider in Latin America, operating in Mexico, Peru, and Colombia, with a focus on prevention and complex diseases [5] - As of June 30, 2025, Auna's network includes 31 healthcare facilities with a total of 2,333 beds and 1.4 million health plan members [5]

Core Insights - Auna S.A. has received a construction license for Torre Trecca, a high-rise outpatient treatment center in Peru, which will be rebuilt and operated under a public-private partnership with EsSalud [1] Company Summary - Auna S.A. is a leading healthcare services provider in Latin America, with operations in Mexico, Peru, and Colombia [1] - The construction of Torre Trecca is part of Auna's ongoing collaboration with EsSalud, Peru's Social Security System [1] Industry Context - The project reflects the growing trend of public-private partnerships in the healthcare sector in Latin America, aimed at improving healthcare infrastructure and services [1]

Core Insights - Auna S.A. has successfully closed a US$765 million debt refinancing, which enhances its capital structure significantly [1] - The refinancing extends debt maturities, reduces interest expenses, and improves cash flow generation [1] - The company aims to utilize the improved financial position to invest in various strategic growth initiatives [1] Company Overview - Auna S.A. is a leading healthcare services provider operating in Latin America, specifically in Mexico, Peru, and Colombia [1] - The company is collaborating with Oncosalud S.A.C. as a co-issuer in this refinancing deal [1]

Core Points - Auna S.A. has successfully priced U.S.$365 million of 8.750% Senior Secured Notes due 2032, which will be co-issued with Oncosalud S.A.C. [1] - The notes will be used to fund a tender offer for Auna's existing 10.000% Senior Secured Notes due 2029 and to prepay existing indebtedness [2] Company Overview - Auna is a leading healthcare platform in Latin America, operating in Mexico, Peru, and Colombia, focusing on prevention and complex diseases [4] - Founded in 1989, Auna has developed a large healthcare network with 31 facilities, including hospitals and wellness centers, serving 1.4 million health plan members [4]

Core Viewpoint - Auna S.A., a Latin American healthcare company, is planning to offer senior secured notes in a private offering to qualified institutional buyers under Rule 144A of the Securities Act of 1933 [1] Group 1 - Auna S.A. operates in Mexico, Peru, and Colombia [1] - The company is collaborating with Oncosalud S.A.C. as co-issuers for the offering of the notes [1]